header advert
Results 1 - 19 of 19
Results per page:
Orthopaedic Proceedings
Vol. 104-B, Issue SUPP_10 | Pages 33 - 33
1 Oct 2022
Ferry T Kolenda C Briot T Craighero F Conrad A Lustig S Bataillers C Laurent F
Full Access

Background

Bacteriophages are natural viruses of interest in the field of PJI. A paper previously reported the PhagoDAIR procedure (use of phages during DAIR) in three patients with PJI for whom explantation was not desirable. As the need to isolate the pathogen before surgery to perform phage susceptibility testing is a strong hindrance for the development of this procedure, we developed post-operative phage injections using ultrasound, in patients infected with S. aureus and/or P. aeruginosa who were eligible for the PhagoDAIR procedure, but for whom phages were not available at the time of surgery.

Materials/Methods

We performed a single center, exploratory, prospective cohort study including patients with knee PJI who received phage therapy with ultrasound after performance of a DAIR or a partial prosthesis exchange. All patients had PJI requiring conservative surgery and suppressive antimicrobial therapy (SAT) as salvage procedure. Each case was discussed in multidisciplinary meetings in agreement with French health authority, based on the clinical presentation, and the phage susceptibility testing. The cocktail of highly concentrate active phages (5 mL; about 10e9 PFU/mL) was extemporaneous prepared and administered three times directly into the joint using sonography (1 injection per week during 3 weeks) during the postoperative period, before switching antibiotics to SAT.


Background

Exebacase, an antistaphylococcal lysin in Phase 3 of development as a treatment for S. aureus bacteremia/right-sided endocarditis has demonstrated antibiofilm activity in vitro and has previously been used as salvage therapy in four patients with relapsing multidrug-resistant (MDR) S. epidermidis knee prosthetic joint infection (PJI) using a procedure called LysinDAIR (administration of the lysin during the performance of an arthroscopic DAIR).

Materials/methods

We performed a single center, exploratory, open-label prospective study using the LysinDAIR procedure in patients with chronic (inoculation >3 months prior to treatment) coagulase-negative staphylococci (CNS) PJI of the knee with two different clinical presentations and treatment paradigms. Cohort A: first episode of CNS knee PJI, for whom the LysinDAIR was followed by clindamycin + levofloxacin planned to be prescribed for three months and then stopped; and Cohort B: relapsing episodes of MDR CNS knee PJI for whom the LysinDAIR was followed by primary antimicrobial therapy for three months, followed by suppressive antimicrobial therapy (SAT). Exebacae susceptibility testing was performed before treatment for each patient. In agreement with the French Health authority, exebacase (2 to 3.5 total mg in 30–50 ml (∼0.067 – 0.075 mg/m) was administered directly into the joint during arthroscopy.


Orthopaedic Proceedings
Vol. 103-B, Issue SUPP_15 | Pages 9 - 9
1 Dec 2021
Ferry T Conrad A Senneville E Roux S Dupieux-Chabert C Dinh A Lustig S Goutelle S Briot T Pham T Valour F
Full Access

Aim

Tedizolid is an oxazolidinone antibiotic that: (i) is recommended at the dose of 200 once daily in patients with skin and soft tissue infection; (ii) seems to have a better long-term hematological and neurological safety profile in comparison with linezolid; (iii) remains active on multidrug-resistant (MDR) Gram-positive pathogens. Consequently, it might represent an option as suppressive antimicrobial treatment (SAT) in patients with complex implant-associated bone and joint infection (BJI) due to MDR Gram-positive pathogens.

Method

We performed a cohort study (2017–2020) to evaluate the long-term safety of tedizolid (200mg qd) as SAT in patients with implant-associated BJI. In all cases, the use of tedizolid was validated as the last oral treatment option during multidisciplinar meetings in a reference center for the management of BJI. Serious adverse events, any reason for discontinuation, and standard biological data, were prospectively collected.


Orthopaedic Proceedings
Vol. 103-B, Issue SUPP_15 | Pages 78 - 78
1 Dec 2021
Benech N LEVAST B Gasc C Cecile B Senneville E Lustig S Boutoille D Dauchy F Zeller V Cazanave C Josse J Laurent F Ferry T
Full Access

Aim

Bone and joint infections (BJI) need frequently prolonged antibiotic treatment at high dosage for a total of 6 or 12 weeks depending the type of infection. Impact of such prolonged antibiotic exposure on the gut microbiota has never been assessed.

Method

We performed a national multicentric prospective study of patients with BJI to monitor the gut microbiota dynamic all along antimicrobial treatment. Clinical data and stool collection were performed at the baseline visit (B) within 24h before starting antibiotics, at the end of the treatment (EOT) and 2 weeks after antibiotic withdrawal during a follow-up visit (FU). Microbiota composition was determined by shotgun metagenomic sequencing. Biological markers of gut permeability and inflammation were monitored at each time point.


Introduction

In prosthetic knee surgery, the axis of the lower limb is often determined only by static radiographic analysis. However, it is relevant to determine if this axis varies during walking, as this may alter the stresses on the implants. The aim of this study was to determine whether pre-operative measurement of the mechanical femorotibial axis (mFTA) varies between static and dynamic analysis in isolated medial femorotibial osteoarthritis.

Methods

Twenty patients scheduled for robotic-assisted medial unicompartmental knee arthroplasty (UKA) were included in this prospective study. We compared three measurements of the coronal femorotibial axis: in a static and weightbearing position (on long leg radiographs), in a dynamic but non-weightbearing position (intra-operative acquisition during robotic-assisted UKA), and in a dynamic and weightbearing position (during walking by a gait analysis).


Orthopaedic Proceedings
Vol. 103-B, Issue SUPP_1 | Pages 60 - 60
1 Feb 2021
Lustig S Batailler C Servien E Foissey C
Full Access

Introduction

Increasingly young and active patients are concerned about revision arthroplasty forcing the manufacturers to think about revision prostheses that fit to this population while meeting the indications and fitting with bone losses and ligament deficiencies. One of those industrials claims that its system allows the surgeon to rise the constraint from a posterior stabilized (PS) prostheses to a semi-constraint total stabilized (TS) prostheses without modifying the gait pattern thanks to a similar single radius design. The aim of the study was to compare gait parameters in patients receiving either PS or TS knee prostheses.

Methods

Nineteen patients in each groups were prospectively collected for this study and compared between each other. All subjects were assessed with a 3D knee kinematics analysis, performed with an optoelectronic knee assessment device (KneeKG®). Were measured for each knees range of motion (ROM) in flexion–extension, abduction–adduction, internal–external rotation and anterior–posterior displacement.


Orthopaedic Proceedings
Vol. 101-B, Issue SUPP_14 | Pages 27 - 27
1 Dec 2019
Triffault-Fillit C Eugenie M Karine C Becker A Evelyne B Michel T Goutelle S Fessy M Dupieux C Laurent F Lustig S Chidiac C Ferry T Valour F
Full Access

Aim

The use of piperacillin/tazobactam with vancomycin as empirical antimicrobial therapy (EAT) for prosthetic joint infection (PJI) has been associated with an increased risk of acute kidney injury (AKI), leading to propose cefepim as an alternative since 2017 in our reference center. The present study compared microbiological efficacy and tolerance of these two EAT strategies.

Method

All patients with PJI empirically treated by vancomycin-cefepim (n=90) were prospectively enrolled in an observational study, and compared with vancomycin-piperacillin/tazobactam-treated historical controls (n=117), regarding: i) the proportion efficacious empirical regimen (i.e., at least one of the two molecules active against the identified organism(s) based on in vitro susceptibility testing); and ii) the incidence of empirical therapy-related adverse events (AE), classified according to the Common terminology criteria for AE (CTCAE).


Orthopaedic Proceedings
Vol. 101-B, Issue SUPP_14 | Pages 26 - 26
1 Dec 2019
Kolenda C Josse J Medina M Fevre C Lustig S Ferry T Laurent F
Full Access

Aim

Staphylococcus aureus is the first causative agent of bone and joints infections (BJI). It causes difficult-to-treat infections because of its ability to form biofilms, and to be internalized and persist inside osteoblastic cells. Recently, phage therapy has emerged as a promising therapy to improve the management of chronic BJI. In the present study, we evaluated the efficacy of an assembly of three bacteriophages previously used in a clinical case report (Ferry, 2018) against S. aureus in in vitro models of biofilm and intracellular osteoblast infection.

Methods

Using HG001 S. aureus, the bactericidal activities of the assembly of the three bacteriophages (Pherecydes Pharma) used alone or in association with vancomycin or rifampicin were compared by quantifying the number of viable bacteria in mature biofilms and infected osteoblasts after 24h of exposure.


Orthopaedic Proceedings
Vol. 100-B, Issue SUPP_17 | Pages 4 - 4
1 Dec 2018
Becker A Triffault-Fillit C Forestier E Lesens O Cazorla C Descamps S Chidiac C Lustig S Montbarbon E Batailler C Boyer B Ferry T
Full Access

Aim

S. aureus and coagulase-negative staphylococci are the most frequent bacteria responsible for PJI. In patients with acute PJI (i.e. <1 month following the implantation), DAIR with exchange of removal components followed by a combination of antibiotics that includes rifampin (particularly rifampin+fluoroquinolone) are recommended. Unfortunately, some patients could not receive rifampin due to drug-drug interaction or stopped it due to an adverse event. Finally, it was unclear if the dose and the duration of rifampin influenced the prognosis.

Method

We performed a retrospective cohort study in 4 hospitals and included patients with staphylococcal acute post-operative (< 1 month) PJI treated with DAIR in 2011–2016 period. Univariate and multivariate Cox analysis and Kaplan Meier curves were used to determine the risk factors for treatment failure (persistence of clinical signs, new surgery w/o persistence or superinfection, infection-related death).


Orthopaedic Proceedings
Vol. 100-B, Issue SUPP_17 | Pages 68 - 68
1 Dec 2018
Abad L Diot A Josse J Tasse J Lustig S Ferry T Laurent F Valour F
Full Access

Aim

Leading etiology of Bone and Join infections (BJI), Staphylococcus aureus (SA) is responsible for difficult-to-treat infections mainly because of three persistence factors: (i) biofilm formation, (ii) persistence within bone cells and (iii) switch to the small colony variant (SCV) phenotype. The impact of rifampin on these mechanisms gave it a prominent place in orthopedic device-associated BJI. However, resistance emergence, intolerance and drug interactions cause significant concerns. In this context, other rifamycins – namely rifapentine and rifabutin – have poorly been evaluated, particularly toward their ability to eradicate biofilm-embedded and intracellular reservoirs of SA.

Method

This study aimed at comparing the intracellular activities of and SCV induction by rifampin, rifabutin and rifapentine in an in vitro model of osteoblast infection. Four concentrations were tested (0.1xMIC, MIC, 10xMIC, 100xMIC) against three SA strains (6850 and two clinical isolates involved in recurrent BJI)


Orthopaedic Proceedings
Vol. 100-B, Issue SUPP_17 | Pages 37 - 37
1 Dec 2018
Dupieux C Verhoeven P Descours G Grattard F Benito Y Vandenesch F Cazorla C Ferry T Lustig S Boyer B Boisset S Laurent F Carricajo A
Full Access

Aims

Microbiological diagnosis of bone and joint infections (BJIs) is pivotal. However, no consensus exists about the best choice for techniques to be used and the best indications for molecular methods. Our objectives were: (i) to compare the performance of various microbiological diagnostic methods (cultural and molecular) on synovial fluid specimens and (ii) to select an algorithm for optimizing the diagnosis of BJIs in adults.

Methods

This prospective multicentric study (in Lyon and Saint-Etienne, France) included 423 joint fluid samples, collected from 333 adult patients (median age 69 years) suspected for BJI on the basis of medical history and clinical symptoms. For each inclusion, joint fluid and blood culture were collected concomitantly. The synovial fluid was also inoculated into blood culture bottles. Cytology, culture (using 5 solid media and an enrichment broth, incubated for 15 days), universal 16S rRNA PCR and PCR targeting Staphylococcus spp, S.aureus, Streptococcus spp, S.pneumoniae, Kingella kingae, Borrelia burgdorferi and Propionibacterium acnes were systematically performed on synovial fluid.


Orthopaedic Proceedings
Vol. 99-B, Issue SUPP_22 | Pages 75 - 75
1 Dec 2017
Chauvelot P Ferry T Triffault-Fillit C Braun E Perpoint T Laurent F Michel-Henry F Lustig S Chidiac C Valour F
Full Access

Aim

Corynebacterium is a rare etiologic agent of BJI. We aimed to describe this rare clinical condition and to assess treatment failure determinants.

Method

All adult patients with proven Corynebacterium BJI (i.e. consistent clinical/radiological signs, AND ≥2 reliable positive bacteriological samples, AND treated as such) were included in a retrospective cohort study. After cohort description, determinants of treatment failure (i.e, infection persistence, relapse, requirement of additional surgical procedure, and BJI-related death) were determined using stepwise logistic regression and Kaplan Meier curve analysis.


Orthopaedic Proceedings
Vol. 99-B, Issue SUPP_22 | Pages 72 - 72
1 Dec 2017
Triffault-Fillit C Valour F Michel T Goutelle S Guillo R Lustig S Fessy M Laurent F Eugenie M Chidiac C Ferry T
Full Access

Aim

Current guidelines recommend the combination of vancomycin with either piperacillin-tazobactam (PT) or a third generation cephalosporin (3GC) as empirical antimicrobial therapy of PJI, immediately after surgery. However, clinical and biological safeties of such high dose-combinations are poorly known.

Method

All patients managed in a reference center in France between 2011 and 2016 receiving an empirical antimicrobial therapy for PJI were included in a prospective cohort study. Antimicrobial-related AE upcoming during the empirical treatment phase were describe according to the Common Terminology Criteria for Adverse Events (CTCEA), and severe ones (grade ≥ 3) were reported to pharmacovigilance. AE determinants were assessed using univariate logistic regression.


Orthopaedic Proceedings
Vol. 98-B, Issue SUPP_23 | Pages 48 - 48
1 Dec 2016
Sophie T Dupieux C Camus C Chidiac C Lustig S Ferry T Laurent F Valour F
Full Access

Aim

Intracellular persistence of S. aureus is believed to be one of the major mechanisms leading to bone and joint infection (BJI) chronicity and relapses. Despite its poor intracellular activity, daptomycin (DAP) is increasingly used in the treatment of staphylococcal BJI. The well-known in vitro synergy of daptomycin with various betalactam antibiotics consequently led us to investigate whether these combinations enhance the activity of daptomycin against the intracellular reservoir of methicillin-susceptible (MSSA) and -resistant (MRSA) S. aureus in an ex-vivo model of human osteoblast infection.

Method

Osteoblastic MG63 cells were infected for 2h with MSSA strain or its isogenic MRSA. After killing the remaining extracellular bacteria with lysostaphin, infected cells were then incubated for 24h with DAP, oxacillin (OXA) or ceftaroline (CPT) alone or in combination, at the intraosseous concentrations reached with standard human therapeutic doses. Intracellular bacteria were then quantified by plating cell lysates. Minimum inhibitory concentrations (MICs) of these molecules alone and in combination were determined using the checkerboard method at pH7, but also at pH5 to mimic intracellular conditions.


Orthopaedic Proceedings
Vol. 95-B, Issue SUPP_29 | Pages 3 - 3
1 Aug 2013
Hobbs H Magnussen R Demey G Lustig S Neyret P Servien E
Full Access

Introduction:

High tibial osteotomy (HTO) is a common treatment for medial compartment arthritis of the knee in younger, more active patients. The HTO shifts load away from the degenerative medial compartment and into the lateral compartment. This change can be accomplished with either a lateral closing or a medial opening wedge HTO. An HTO also potentially affects leg length. Mathematical models predict that the osteotomy type (opening versus closing) and the magnitude of the correction determine the change in leg length, but no in vivo studies have been published. The purpose of this study is to quantify and compare leg length change following opening and closing wedge HTO.

Study Design:

Retrospective cohort study – Level III evidence


Orthopaedic Proceedings
Vol. 95-B, Issue SUPP_29 | Pages 26 - 26
1 Aug 2013
Hobbs H Magnussen R Demey G Lustig S Servien E Neyret P
Full Access

Background:

Appropriate positioning of total knee arthroplasty (TKA) components is a key concern of surgeons. Post-operative varus alignment has been associated with poorer clinical outcome scores and increased failure rates. However, obtaining neutral alignment can be challenging in cases with significant pre-operative varus deformity

Questions:

1) In patients with pre-operative varus deformities, does residual post-operative varus limb alignment lead to increased revision rates or poorer outcome scores compared to correction to neutral alignment? 2) Does placing the tibial component in varus alignment lead to increased revision rates and poorer outcome scores? 3) Does femoral component alignment affect revision rates and outcome scores? 4) Do these findings change in patients with at least 10 degrees of varus alignment pre-operatively?


Orthopaedic Proceedings
Vol. 95-B, Issue SUPP_15 | Pages 245 - 245
1 Mar 2013
Lustig S Scholes C Oussedik S Appleyard R Parker D
Full Access

Introduction & aims

Osteonecrosis may be triggered by bone temperature above 45°C during routine orthopaedic bone cuts using power-driven saws, with potentially negative impacts on bone healing. A new oscillating-tip saw blade design (Precision; Stryker, Kalamazoo, Mich) has been recently developed but the saw blade design may influence the amount of heat generated. We have therefore sought to compare the bone temperature during a standardised cutting task with two different saw blade designs.

Method

Three pairs of human cadaveric femora were obtained. Each femur was clamped and a distal femoral cutting jig was applied. An initial cut was performed to visualise the distal metaphyseal bone. The cutting block was then moved 2 mm proximal and a further cut performed, measuring the temperature of the bone with an infra-red camera. This was repeated, moving the block 2 mm proximal with each cut, alternating between a standard oscillating saw blade and the “Precision” saw blade. The density of the cut bone was then established from a CT scan of each specimen performed prior to the experiment.


Orthopaedic Proceedings
Vol. 95-B, Issue SUPP_15 | Pages 246 - 246
1 Mar 2013
Lustig S Servien E Demey G Neyret P
Full Access

For many patients, UKA is a good alternative to total knee arthroplasty (TKA) or high tibial osteotomy (HTO). Strong evidence that gender influences outcomes following UKA could alter UKA selection criteria. No prior series has been specifically designed and matched to compare outcomes based on gender. The purpose of this study was to elucidate the effect of gender on the clinical outcome of UKA while controlling for other variables that may affect outcome.

Between 1988 and 2006, 257 UKA's were carried out in our department. We studied two groups of 40 patients of each gender, matched by pre-operative clinical and radiological presentation, and with post-operative follow up of at least 2 years. The mean age at operation was 71 years and the mean follow-up was 5.9 years. In both groups, IKS score improved significantly.

When comparing the male and female groups post-operatively, no significant differences were found between IKS knee or function scores, limb alignment, or the incidence of radiolucent lines. No difference was found between groups in terms of range of motion or radiologic progression of arthritis. Both tibial (p<0.001) and femoral (p<0.001) component sizes were significantly larger in the male group than the female group. For males, the size of both the femoral (r2=0.12, p=0.033) and tibial (r2=0.29, p=0.0005) components correlated with patient height. For females, the size of neither the femoral (r2=0.000082, p=0.96) nor tibial (r2=0.0065, p=0.63) components correlated with patient height.

The key finding in this study is that when patients are selected for UKA according to specific selection criteria (including avoiding performance of UKA in younger patients and patients over 85 kg), gender is not a predictor of outcome based on IKS scores. When using these selection criteria, gender should not be considered when determining whether to perform a UKA.


Orthopaedic Proceedings
Vol. 95-B, Issue SUPP_15 | Pages 299 - 299
1 Mar 2013
Parker D Lustig S Scholes C Kinzel V Oussedik S Coolican M
Full Access

Purpose

Patient-matched instrumentation is advocated as the latest development in arthroplasty surgery. Custom-made cutting blocks created from preoperative MRI scans have been proposed to achieve perfect alignment of the lower limb in total knee arthroplasty (TKA). The aim of this study was to determine the efficacy of patient-specific cutting blocks by comparing them to navigation, the current gold standard.

Methods

60 TKA patients were recruited to undergo their surgery guided by Smith & Nephew Visionaire Patient-Matched cutting blocks. Continuous computer navigation was used during the surgery to evaluate the accuracy of the cutting blocks. The blocks were assessed for the fit to the articular surface, as well as alignment in the coronal, sagittal and rotational planes, sizing, and resection depth.